Hypothyroidism is a common and chronic condition. Finding a high concentration of thyroid stimulating hormone in a symptomatic patient confirms the diagnosis and a cause is usually readily found. lifelong thyroxine therapy relieves symptoms and restores 'normal' thyroid function. Commencing thyroxine can aggravate cardiac disease but is relatively free of adverse effects. The concentration of thyroid stimulating hormone is used to monitor therapy.
Introduction
Hypothyroidism is a common condition with an annual incidence of 3.5/1000 in women and 0.6/1000 in men. 1 The prevalence increases with age. In areas without iodine deficiency the common causes of chronic hypothyroidism are autoimmune thyroid disease, thyroidectomy, radiotherapy (both radioiodine therapy and external beam radiotherapy), congenital disorders and disorders of thyroid hormone metabolism.
Secondary hypothyroidism occurs with some pituitary and hypothalamic diseases.
Diagnosis
Patients may not present with the typical clinical features of hypothyroidism. They may have vague symptoms such as tiredness. The diagnosis can be made by finding a persistently elevated serum concentration of thyroid stimulating hormone (TSH). The serum free thyroxine (fT4) concentration will be low.
Measuring triiodothyronine (fT3) adds little to the diagnosis or monitoring of hypothyroidism.
In secondary hypothyroidism the pituitary fails to produce TSH appropriately so measurement of TSH is unhelpful. The diagnosis is suggested by a low fT4 and features of pituitary disorder.
In subclinical hypothyroidism the TSH is elevated (usually to 5-10 mIU/L) but the fT4 is normal. The typical symptoms of hypothyroidism are often absent.
The cause of primary hypothyroidism in an adult will usually be determined from a history of thyroidectomy or radiotherapy or finding high titres of antithyroid antibodies (thyroid peroxidase, antimicrosomal or antithyroglobulin antibodies).
The use of lithium and iodine-containing preparations (such as amiodarone) can cause a drug-induced hypothyroidism.
Providing patients with a copy of the laboratory results which confirm their need for thyroxine often proves helpful for the patient and future treating doctors.
Treatment
Primary hypothyroidism is treated by giving the patient replacement thyroxine, usually for life. Liothyronine rarely needs to be used unless there is life-threatening hypothyroidism.
Alternative sources of thyroid hormones such as thyroid extracts should be avoided.
Thyroxine dose
Thyroxine has a half-life of 7-10 days but a much longer biological effect. Once-daily dosing is appropriate.
The dose is dependent on body weight and age. Children Thyroxine tablets should be kept dry and cool and in their original container. 3 Recent advice to refrigerate thyroxine tablets increases the likelihood of moisture causing deterioration in the medication. A month's supply can be kept at room temperature. 4 
Starting thyroxine
The rate of introduction of thyroxine should be determined by For patients between these two extremes, a starting dose of 50 microgram/day is reasonable. This is increased at intervals of 3-4 weeks until the predicted dose is reached.
Patients should feel some symptomatic improvement within two weeks of starting thyroxine. It may take 3-4 months for the full benefit of the drug to become apparent and for the TSH to normalise.
monitoring and dose adjustment
In primary hypothyroidism the TSH alone can be used to 
Problems
If taken correctly, thyroxine should enable patients to lead a normal life. However, there are some common problems which can affect management.
Persistently elevated TSH
Poor adherence is the most likely explanation of TSH remaining above the normal range. I advise patients to decant a week's supply of thyroxine into a separately labelled bottle and refill the bottle on the same day each week. If the patient discovers they have missed one (or more) doses they can take the missed doses in conjunction with their usual dose over the next few days.
The absorption of thyroxine may be reduced by cholestyramine, colestipol, aluminium hydroxide, ferrous sulfate and possibly fibre. Two hours should elapse between use of thyroxine and these drugs.
Symptoms do not respond to thyroxine
Hypothyroidism is often discovered on biochemical testing after patients present with non-specific complaints. While it is likely that symptoms such as muscle aches and pains, dry skin and 
Secondary hypothyroidism
If there is pituitary or hypothalamic disease, TSH is unreliable for diagnosing and monitoring thyroid function and fT4 should be used instead. A low fT4 will be found in secondary hypothyroidism and treatment should aim to maintain fT4 within the reference range.
Most patients with secondary hypothyroidism will be hypogonadal and many will also be cortisol deficient. It is extremely important to consider cortisol deficiency before starting treatment with thyroxine in patients with pituitary and hypothalamic disease as its use will speed the metabolism of cortisol and can induce an adrenal crisis.
When commencing thyroxine in secondary hypothyroidism it is therefore safest to also treat the patient with a corticosteroid (for example prednisone 5 mg daily). Subsequently, cortisol reserve can be assessed with an early morning cortisol measurement. 
Pregnancy and lactation
Thyroxine requirements increase by 25-30% during pregnancy with increased requirements seen as early as the fifth week of pregnancy. 6 Children born to women whose hypothyroidism was inadequately treated in pregnancy are at increased risk of neuropsychological impairment. 
Addison's disease
Addison's disease and autoimmune hypothyroidism occasionally occur together. This is a rare but dangerous association. Increased pigmentation, postural hypotension and possibly weight loss may suggest the additional diagnosis. As in secondary hypothyroidism, give steroid replacement before introducing thyroxine to avoid inducing an adrenal crisis.
Thyroid cancer
Some patients with differentiated thyroid cancer are given thyroxine at a higher dose to suppress TSH (to less than 0.1 mIU/L) with minimum elevation of fT4. This helps prevent recurrence of the cancer.
Conclusion
Treatment of hypothyroidism is usually a lifelong necessity.
Determining the cause will detect those patients who need only transient treatment.
Except for those patients with or at risk of known cardiac disease, the elderly and those with long-standing symptoms, thyroxine can usually be commenced at or near a full replacement dose. The dose is adjusted to keep the concentration of TSH within the normal range.
